Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
11/2010
11/04/2010CA2758965A1 Methods for the preparation of amphiphilic nitrogen containing imidazolinium derivative compounds
11/03/2010EP2245022A2 Antagonists of prostaglandin d2 receptors
11/03/2010EP1831179B1 Method for the production of onium salts with tetrafluoroborate anion having a reduced halide content
11/03/2010EP1496838B1 Substituted amides
11/03/2010CN101878202A Gamma secretase modulators
11/03/2010CN101875636A Imidazoline-2,4-diketone derivative and preparation method and applications thereof
11/03/2010CN101875635A Annular guanidinium ionic liquid and preparation method therof
11/03/2010CN101215330B Method for preparing 1-aminohydantoin artificial antigen
11/02/2010US7825259 Method of preparation of halogen-free ionic liquids and ionic liquids prepared in this manner
11/02/2010US7825193 Dithiocarbamic esters
11/02/2010US7825150 Compositions and methods for treating immunological and inflammatory diseases and disorders
11/02/2010US7825149 such as 2-[1-(2-chloro-3-methylphenyl)ethyl]-1H-imidazole, used for the treatment of parasitic infection in plants or animals ; parasiticides
11/02/2010US7825142 imidazole-based compounds such as (1R,2S,3R)-1-(2-(5-methylisoxazol-3-yl)-1H-imidazol-5-yl)butane-1,2,3,4-tetraol, used for the treatment and prevention of inflammatory and autoimmune diseases
11/02/2010CA2389681C Npy y5 antagonist
11/02/2010CA2311456C Imidazonaphthyridines and their use in inducing cytokine biosynthesis
10/2010
10/28/2010WO2010123150A1 2-aryl imidazoline derivatives
10/28/2010WO2010122995A1 Imidazole compound-containing microcapsulated composition, curable composition using same, and masterbatch type curing agent
10/28/2010WO2010122927A1 Pharmaceutical agent for prevention or treatment of retarded nerve regeneration induced by diabetes
10/28/2010WO2009127338A8 Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof
10/28/2010US20100273849 Metalloproteinase Inhibitors
10/28/2010US20100273848 Iminopyrrolidone thiol amino acid conjugates, pharmaceutical compositions and methods for the treatment of cancer
10/28/2010US20100273833 2-sulfinyl- and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors
10/28/2010US20100273801 Betulin derived compounds useful as antibacterial agents
10/28/2010US20100273739 Aminotetraline Derivatives, Pharmaceutical Composition, Containing Them, and Their Use in Therapy
10/27/2010EP2243539A2 Functionalized ionic liquids, and methods of use thereof
10/27/2010EP2242748A1 Therapeutic disulfide compounds for treating pain and diabetes
10/27/2010EP2242746A1 Heterocyclically-substituted imidazolidine-2,4-diones, method for the production thereof, medicaments containing said compounds and use thereof
10/27/2010EP2242745A1 Novel phenyl-substituted imidazolidines, method for the production thereof, medicaments containing said compounds and use thereof
10/27/2010EP2242744A1 Process for working up ionic liquids
10/27/2010EP1279667B1 Process for producing 1,3-dialkyl-2-imidazolidinone compound
10/27/2010CN1819996B Naphthylene derivatives as cytochrome P450 inhibitors
10/27/2010CN101870705A Novel organic compound, light-emitting device, and image display apparatus
10/27/2010CN101870691A 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
10/27/2010CN101870680A Preparation method and use of tertiary amino functional imidazole ionic liquid
10/27/2010CN101870679A Preparation method of N-(2-aminoethyl)-2-imidazolidone
10/26/2010US7820825 N-substituted-azacyclylamines as histamine-3 antagonists
10/26/2010US7820673 Urea derivative, process for producing the same, and use
10/26/2010CA2293436C Imidazolyl-cyclic acetals as tnf inhibitors
10/26/2010CA2289408C Corrosion inhibitor compositions
10/21/2010WO2010119193A1 Imidazolidine-2,4-dione derivatives, and use thereof as a cancer drug
10/21/2010US20100267962 N-acylic aminoacid derivatives, method for the production thereof, pharmacological composition and the use in the form anti-allergic, anti-inflammatory and hypolipidemic agents
10/21/2010US20100267795 Nitrosubstituted aryloxyalkylimidazolines for use as pesticides
10/21/2010US20100267698 Benzimidazole and Pyridylimidazole Derivatives
10/21/2010CA2758630A1 Imidazolidine-2, 4-dioze derivatives, and use thereof as a cancer drug
10/21/2010CA2758245A1 Gamma-amino-butyric acid derivatives as gabab receptor ligands
10/20/2010EP2241320A1 Aqueous compositions containing metronidazole
10/20/2010EP2240480A2 Derivatives of 2-heteroaroyl-imidazol(1,2-a)pyridine,preparation thereof and therapeutic application thereof
10/20/2010EP2240468A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof
10/20/2010EP2240453A1 Substituted-aryl-2-phenylethyl-1h-imidazole compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors
10/20/2010EP2240019A1 Acid mimic compounds for the inhibition of isoprenyl-s-cysteinyl methyltransferase
10/20/2010EP1780197B1 5-substituted-2-phenylamino benzamides as mek inhibitors
10/20/2010CN101863841A Substituted tetracycline compounds
10/20/2010CN101863837A Water-soluble salt of secnidazole and preparation method thereof
10/20/2010CN101863836A Method for preparing 5,5-diphenyl-2-thiohydantoin
10/20/2010CN101863835A Synthesis method of S-substituted-5,5-diphenyl-2-thiohydantoin derivatives
10/20/2010CN101863834A Preparation method of S-carboxymethyl-5,5-diphenyl-2-thiohydantoin
10/20/2010CN101863833A Preparation method of 3-carboxymethyl-5,5-diphenyl hydantoin
10/20/2010CN101863832A Method for producing miconazole nitrate on industrialized basis
10/20/2010CN101863795A Method for preparing hydrogel material based on 1,4-cyclohexane/phthalic acid
10/19/2010US7816534 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/19/2010US7816522 Triazolone derivatives
10/19/2010US7816389 Organic compounds
10/19/2010US7816387 β secretase inhibitor
10/19/2010US7816375 Ligands for monoamine receptors and transporters, and methods of use thereof
10/19/2010US7816360 MTP inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
10/19/2010CA2614479C Derivatives of seleno-amino acids
10/19/2010CA2436589C Heterocyclic compounds and cognitive enhancers comprising the same as effective components
10/19/2010CA2436526C Heterocyclic sulfonamide inhibitors of beta amyloid production
10/19/2010CA2214338C Use of .alpha.1l agonists for treating urinary incontinence
10/14/2010WO2010118377A2 Molecular sieves and related methods and structure directing agents
10/14/2010WO2010117108A1 Polyacetylene supramolecular sieve having selectivity for cationic or anionic compounds, and chemical sensor for detecting cationic or anionic compounds using same
10/14/2010WO2010117040A1 Five-membered heterocyclic compound
10/14/2010WO2010116166A2 Process for the preparation of chalcogene compounds
10/14/2010WO2010116165A2 Process for removing metals from hydrocarbons
10/14/2010WO2010115937A1 Process for preparing pyrrolidinium salts
10/14/2010WO2009144395A8 Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2- α] pyridines, and preparation and therapeutic use thereof
10/14/2010WO2009144394A8 Polysubstituted 2-aryl-6-phenyl-imidazo[1,2-α]pyridine derivatives, and preparation and therapeutic use thereof
10/14/2010US20100261913 Method for producing precursors for l-3,4-dihydroxy-6- [18f] fluorophenyl alaine and 2- [18f] fluoro-l-tyrosine and the alpha-methylated derivatives thereof, precursor, and method for producing l-3, 4dihydroxy-6- [18f] fluorophenylalanine and 2- [18f] fluoro-l-tyrosine and the alpha-methylated derivatives from the precursor
10/14/2010US20100261899 Imidazole compounds
10/14/2010US20100261898 Imidazole compounds
10/14/2010US20100261760 EP2 Receptor Agonists
10/14/2010US20100261758 Heterocyclic amides for use as pharmaceuticals
10/14/2010US20100261631 Biofilm-removing agent
10/14/2010CA2758100A1 Process for preparing pyrrolidinium salts
10/14/2010CA2757854A1 Molecular sieves and related methods and structure directing agents
10/13/2010EP2238980A1 Aqueous compositions containing metronidazole
10/13/2010EP2238116A1 Novel imidazolinylmethyl aryl sulfonamides
10/13/2010EP2238115A1 Novel imidazolinylmethyl aryl sulfonamides
10/13/2010EP2238114A1 Novel imidazolinylmethyl aryl sulfonamides
10/13/2010EP2238113A1 N-[3-bromo-2-chloro-4-(4, 5-dihydro-1h-imidazol-2-ylmethyl)-phenyl] -methanesulfoamide as alpha-1 a adrenergic partial agonist for the treatment of incontinence
10/13/2010EP1370537B1 Metalloproteinase inhibitors
10/13/2010CN1839122B Ioninc liquids based on imidazolium salts incorporating a nitrile functionality
10/13/2010CN101861093A Haloalkylsubstituted aryloxyalkylimidazolines for use as pesticides
10/13/2010CN101468969B Photoresponse ion liquid and preparation thereof
10/12/2010US7812174 Methods of preparing imidazole-based compounds
10/12/2010US7812049 alpha 1-adrenoceptor agonists for treating skin redness; oxymetazoline hydrochloride
10/12/2010US7812048 N-[3-[(2S)-1-methoxypropan-2-yl]oxy-5-(4-methylsulfonylphenoxy)phenyl]-1H-imidazole-5-carboxamide, used as antidiabetic agents, especially for the treatment of non-insulin dependent diabetes
10/12/2010US7812047 4-imidazolines
10/12/2010US7812045 1-(5-(4-trifluoromethyl-benzylamino)-1H-indazol-1-yl)-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol; 2-(2,4-difluorophenyl)-1-(1H-indazol-1-yl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol
10/12/2010US7812041 such as 2-Morpholin-4-yl-thiazole-4-carboxylic acid (5,6-dimethyl-1H-benzoimidazol-2-yl)-amide, used for the treatment of dementia, amyotrophic lateral sclerosis, stroke, epilepsy, multiple sclerosis, myasthenia gravis, Huntington's, Alzheimer's, Parkinson's, Meniere's and Creutzfeld-Jacob Disease
1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 345